These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 15646365

  • 1. Properties of olopatadine hydrochloride, a new antiallergic/antihistaminic drug.
    Ohmori K, Hasegawa K, Tamura T, Miyake K, Matsubara M, Masaki S, Karasawa A, Urayama N, Horikoshi K, Kajita J, Hasegawa M, Taniguchi K, Komada T, Kawamoto Y.
    Arzneimittelforschung; 2004; 54(12):809-29. PubMed ID: 15646365
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
    Ohmori K, Hayashi K, Kaise T, Ohshima E, Kobayashi S, Yamazaki T, Mukouyama A.
    Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride' (olopatadine), an antiallergic drug].
    Ohmori K, Ikemura T, Kobayashi H, Mukouyama A.
    Nihon Yakurigaku Zasshi; 2001 Jul; 118(1):51-8. PubMed ID: 11496828
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA, Xu SX, Miller ST, Gamache DA, Yanni JM.
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [Abstract] [Full Text] [Related]

  • 5. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM, Stephens DJ, Miller ST, Weimer LK, Graff G, Parnell D, Lang LS, Spellman JM, Brady MT, Gamache DA.
    J Ocul Pharmacol Ther; 1996 Sep; 12(4):389-400. PubMed ID: 8951675
    [Abstract] [Full Text] [Related]

  • 6. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB, Gomes PJ, Vogelson CT, Pasquine TA, Turner FD, Wells DT, Robertson SM.
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model.
    Abelson MB.
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):211-8. PubMed ID: 9759796
    [Abstract] [Full Text] [Related]

  • 8. Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.
    Vogelson CT, Abelson MB, Pasquine T, Stephens DM, Gamache DA, Gross RD, Robertson SM, Yanni JM.
    Allergy Asthma Proc; 2004 Sep; 25(1):69-75. PubMed ID: 15055565
    [Abstract] [Full Text] [Related]

  • 9. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
    Lanier BQ, Gross RD, Marks BB, Cockrum PC, Juniper EF.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):641-8. PubMed ID: 11428736
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV, Udell IJ.
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [Abstract] [Full Text] [Related]

  • 11. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA, Xu SX, Yanni JM.
    J Ocul Pharmacol Ther; 1996 May; 12(4):401-7. PubMed ID: 8951676
    [Abstract] [Full Text] [Related]

  • 12. A review of olopatadine for the treatment of ocular allergy.
    Abelson MB.
    Expert Opin Pharmacother; 2004 Sep; 5(9):1979-94. PubMed ID: 15330735
    [Abstract] [Full Text] [Related]

  • 13. Effect of (Z)-11-[3-(dimethylamino) propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride on experimental allergic conjunctivitis and rhinitis in rats and guinea pigs.
    Kamei C, Sugimoto Y, Nakamura S, Zhong C.
    Arzneimittelforschung; 1995 Sep; 45(9):1005-8. PubMed ID: 7488300
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
    Tamura T, Kimoto N.
    Pharmacology; 2009 Sep; 84(5):288-93. PubMed ID: 19816088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
    Mah FS, O'Brien T, Kim T, Torkildsen G.
    Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.
    Nickels AS, Dimov V, Wolf R.
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1593-9. PubMed ID: 22032416
    [Abstract] [Full Text] [Related]

  • 19. Olopatadine hydrochloride in children: efficacy and safety for perennial allergic rhinitis.
    Okubo K, Okuda M, Magara H, Kaneko K.
    Curr Med Res Opin; 2010 Jul; 26(7):1657-65. PubMed ID: 20443650
    [Abstract] [Full Text] [Related]

  • 20. [The effect of KW-4679, an antiallergic drug, on experimental allergic rhinitis].
    Kaise T, Manabe H, Ohmori K.
    Arerugi; 1995 Oct; 44(10):1229-33. PubMed ID: 8579485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.